… Silica is “Generally Recognized As Safe” by the United States Food and Drug Administration
(FDA). Recently, silica nanoparticles in the form of Cornell dots (C dots) received FDA …

… organically modified silica (ORMOSIL) nanoparticles as a nonviral vector for efficient in vivo
gene delivery. Highly monodispersed, stable aqueous suspension of nanoparticles, surface-…

… Surface coating of silica nanoparticles with polycations is an alternative method to … cationic
silica nanoparticles for gene delivery. For example, surface-functionalized silica nanoparticles …

… utilization of nanoparticles on plant research. Here, we employed functionalized mesoporous
silica nanoparticles (MSNs) to develop a MSN-mediated plant transient gene expression …

… In this work, we used PDMAEA covalently attached to the surface of large pore mesoporous
silica nanoparticles (PDMAEA–LPMSNs) to act as a dual delivery system. The surface …

… We demonstrated in this study that functionalized large pore mesoporous silica
nanoparticles with cubic mesostructure have a true potential for delivery of nucleic acids in high …

… Inorganic nanoparticles provide new and promising aspects as gene and drug transfer …
Amorphous silica nanoparticles are favoured since SiO 2 is a nontoxic compound present in a lot …

… encapsulation of drugs and genes, large surface area … silica nanoparticles (MMSN)
possessing very large pores (>15 nm) and application of the nanoparticles to plasmid DNA delivery …

… silica nanoparticles in gene delivery systems, either through simple electrostatic interactions
with the surface silanol groups, through covalent silane coupling with trialkoxysilanes, or by …

… in the research of intracellular drug/gene delivery. In particular, numerous surface-functionalized,
end-capped mesoporous silica nanoparticle (MSN) materials have been designed as …